Literature DB >> 21716154

Neuromodulation in epilepsy.

Faisal A Al-Otaibi1, Clement Hamani, Andres M Lozano.   

Abstract

Neuromodulation strategies have been proposed to treat a variety of neurological disorders, including medication-resistant epilepsy. Electrical stimulation of both central and peripheral nervous systems has emerged as a possible alternative for patients who are not deemed to be good candidates for resective procedures. In addition to well-established treatments such as vagus nerve stimulation, epilepsy centers around the world are investigating the safety and efficacy of neurostimulation at different brain targets, including the hippocampus, thalamus, and subthalamic nucleus. Also promising are the preliminary results of responsive neuromodulation studies, which involve the delivery of stimulation to the brain in response to detected epileptiform or preepileptiform activity. In addition to electrical stimulation, novel therapeutic methods that may open new horizons in the management of epilepsy include transcranial magnetic stimulation, focal drug delivery, cellular transplantation, and gene therapy. We review the current strategies and future applications of neuromodulation in epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21716154     DOI: 10.1227/NEU.0b013e31822b30cd

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

1.  Frequency dependence of behavioral modulation by hippocampal electrical stimulation.

Authors:  Giorgio La Corte; Yina Wei; Nick Chernyy; Bruce J Gluckman; Steven J Schiff
Journal:  J Neurophysiol       Date:  2013-11-06       Impact factor: 2.714

Review 2.  Deep brain stimulation for the treatment of epilepsy: circuits, targets, and trials.

Authors:  Nealen G Laxpati; Willard S Kasoff; Robert E Gross
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

3.  Modeling noninvasive neurostimulation in epilepsy as stochastic interference in brain networks.

Authors:  Catherine Stamoulis; Bernard S Chang
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2012-06-04       Impact factor: 3.802

4.  State-dependent and -independent effects of dialyzing excitatory neuromodulator receptor antagonists into the ventral respiratory column.

Authors:  Thomas M Langer; Suzanne E Neumueller; Emma Crumley; Nicholas J Burgraff; Sawan Talwar; Matthew R Hodges; Lawrence Pan; Hubert V Forster
Journal:  J Appl Physiol (1985)       Date:  2016-09-29

5.  Restoring Conscious Arousal During Focal Limbic Seizures with Deep Brain Stimulation.

Authors:  Adam J Kundishora; Abhijeet Gummadavelli; Chanthia Ma; Mengran Liu; Cian McCafferty; Nicholas D Schiff; Jon T Willie; Robert E Gross; Jason Gerrard; Hal Blumenfeld
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

6.  Epileptic neuronal networks: methods of identification and clinical relevance.

Authors:  Hermann Stefan; Fernando H Lopes da Silva
Journal:  Front Neurol       Date:  2013-03-01       Impact factor: 4.003

7.  Novel applications of deep brain stimulation.

Authors:  Tejas Sankar; Travis S Tierney; Clement Hamani
Journal:  Surg Neurol Int       Date:  2012-01-14

8.  Brain stimulation for intractable epilepsy: Anterior thalamus and responsive stimulation.

Authors:  Vibhor Krishna; Andres M Lozano
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

9.  A computational study of stimulus driven epileptic seizure abatement.

Authors:  Peter Neal Taylor; Yujiang Wang; Marc Goodfellow; Justin Dauwels; Friederike Moeller; Ulrich Stephani; Gerold Baier
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

10.  Effects of anterior thalamic nucleus deep brain stimulation in chronic epileptic rats.

Authors:  Luciene Covolan; Antônio-Carlos G de Almeida; Beatriz Amorim; Clarissa Cavarsan; Maisa Ferreira Miranda; Mayra C Aarão; Ana Paula Madureira; Antônio M Rodrigues; José N Nobrega; Luiz E Mello; Clement Hamani
Journal:  PLoS One       Date:  2014-06-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.